Literature DB >> 20884677

Dissociation in hysteria and hypnosis: evidence from cognitive neuroscience.

Vaughan Bell1, David A Oakley, Peter W Halligan, Quinton Deeley.   

Abstract

Jean-Martin Charcot proposed the radical hypothesis that similar brain processes were responsible for the unexplained neurological symptoms of 'hysteria', now typically diagnosed as 'conversion disorder' or 'dissociative (conversion) disorder', and the temporary effects of hypnosis. While this idea has been largely ignored, recent cognitive neuroscience studies indicate that (i) hypnotisability traits are associated with a tendency to develop dissociative symptoms in the sensorimotor domain; (ii) dissociative symptoms can be modelled with suggestions in highly hypnotisable subjects; and (iii) hypnotic phenomena engage brain processes similar to those seen in patients with symptoms of hysteria. One clear theme to emerge from the findings is that 'symptom' presentation, whether clinically diagnosed or simulated using hypnosis, is associated with increases in prefrontal cortex activity suggesting that intervention by the executive system in both automatic and voluntary cognitive processing is common to both hysteria and hypnosis. Nevertheless, while the recent literature provides some compelling leads into the understanding of these phenomena, the field still lacks well controlled systematically designed studies to give a clear insight into the neurocognitive processes underlying dissociation in both hysteria and hypnosis. The aim of this review is to provide an agenda for future research.

Entities:  

Mesh:

Year:  2010        PMID: 20884677     DOI: 10.1136/jnnp.2009.199158

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

Review 1.  Hypnotic suggestion: opportunities for cognitive neuroscience.

Authors:  David A Oakley; Peter W Halligan
Journal:  Nat Rev Neurosci       Date:  2013-07-17       Impact factor: 34.870

2.  Treatment of functional motor disorders.

Authors:  Jeannette M Gelauff; Yasmine E M Dreissen; Marina A J Tijssen; Jon Stone
Journal:  Curr Treat Options Neurol       Date:  2014-04       Impact factor: 3.598

3.  Brain Activity and Functional Connectivity Associated with Hypnosis.

Authors:  Heidi Jiang; Matthew P White; Michael D Greicius; Lynn C Waelde; David Spiegel
Journal:  Cereb Cortex       Date:  2017-08-01       Impact factor: 5.357

Review 4.  Treatment of functional (psychogenic) movement disorders.

Authors:  Luciana Ricciardi; Mark J Edwards
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 5.  An integrative neurocircuit perspective on psychogenic nonepileptic seizures and functional movement disorders: neural functional unawareness.

Authors:  David L Perez; Barbara A Dworetzky; Bradford C Dickerson; Lorene Leung; Rachel Cohn; Gaston Baslet; David A Silbersweig
Journal:  Clin EEG Neurosci       Date:  2014-11-27       Impact factor: 1.843

6.  Treatment of conversion disorder in the 21st century: have we moved beyond the couch?

Authors:  Patricia I Rosebush; Michael F Mazurek
Journal:  Curr Treat Options Neurol       Date:  2011-06       Impact factor: 3.598

Review 7.  Neuro-hypnotism: prospects for hypnosis and neuroscience.

Authors:  John F Kihlstrom
Journal:  Cortex       Date:  2012-06-05       Impact factor: 4.027

8.  Deepening sleep by hypnotic suggestion.

Authors:  Maren J Cordi; Angelika A Schlarb; Björn Rasch
Journal:  Sleep       Date:  2014-06-01       Impact factor: 5.849

9.  The functional neuroimaging correlates of psychogenic versus organic dystonia.

Authors:  Anette E Schrag; Arpan R Mehta; Kailash P Bhatia; Richard J Brown; Richard S J Frackowiak; Michael R Trimble; Nicholas S Ward; James B Rowe
Journal:  Brain       Date:  2013-03       Impact factor: 13.501

10.  A Bayesian account of 'hysteria'.

Authors:  Mark J Edwards; Rick A Adams; Harriet Brown; Isabel Pareés; Karl J Friston
Journal:  Brain       Date:  2012-05-28       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.